Peter Virsik - Jan 5, 2024 Form 4 Insider Report for ESSA Pharma Inc. (EPIX)

Role
Chief Operating Officer
Signature
/s/ Peter Virsik
Stock symbol
EPIX
Transactions as of
Jan 5, 2024
Transactions value $
-$4,271
Form type
4
Date filed
1/8/2024, 08:06 PM
Previous filing
Nov 1, 2022
Next filing
Jan 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EPIX Common Shares Sale -$4.27K -699 -4.75% $6.11 14K Jan 5, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The amount reflects the sale of shares pursuant to Mr. Virsik's 10b5-1 trading plan. The Rule 10b5-1 trading plan was entered into on August 31, 2023.